Pharmaceutical / Drug Definition :
Exerts anticholinergic, CNS depressant, and antihistaminic effects. Depresses release of hypothalamic and hypophyseal hormones, decreases sensitivity of middle-ear labyrinth, and reduces conduction in vestibular-cerebellar pathways.
In the United States, Prochlorperazine is regulated by the U.S. Food and Drug Administration (FDA). FDA has specific requirements regarding the registration and listing of Prochlorperazine.
FDA Label Requirements and Exceptions
FDA Import Information
Prochlorperazine (Prochlorperazine Entry Refusal)
General U.S. Food and Drug Administration Guidelines for:
- Manufacturers Prochlorperazine (Prochlorperazine Suppliers)
- Processors Prochlorperazine
- Repackers Prochlorperazine
- Relabelers Prochlorperazine
- Exporters Prochlorperazine
- Importers Prochlorperazine
For more information about Prochlorperazine, simply click below:
U.S. FDA Regulations:
U.S. FDA Regulation: 21 C.F.R. Part 207
Registrar Corp assists businesses with U.S. FDA compliance. Certificates of Registration issued by Registrar Corp provide confirmation to industry that you are fulfilling U.S. FDA registration requirements. U.S. FDA does not issue or recognize Certificates of Registration. Registrar Corp is not affiliated with the U.S. Food and Drug Administration.